Publications
Research projects supported by the Chalmers Mass Spectrometry Infrastructure (CMSI) have contributed to publications across metabolomics, lipidomics, analytical method development and a broad range of life science applications.
Below, you will find peer-reviewed publications from the past three years that are based on analyses performed at CMSI or otherwise include contributions from the infrastructure.
For a complete and continuously updated list of publications associated with CMSI, please visit the SciLifeLab Infrastructure Units Publications database.
2026
• González-Domínguez Á, Domínguez-Riscart J, Savolainen O, Lechuga-Sancho A, Landberg R, González-Domínguez R. Obesity and insulin resistance trigger the early onset of adolescent-like sexually dimorphic metabotypes in middle childhood. Cardiovascular Diabetology. 2026. DOI: 10.1186/s12933-026-03172-6.
• Dutta T, Kovooru L, Thorsell A, Pujia C, Maurotti S, Sasidharan K, Mancina RM, Romeo S. Di-lineage hepatic spheroids from human donors capture steatotic liver disease. Cellular and Molecular Gastroenterology and Hepatology. 2026:101804. DOI: 10.1016/j.jcmgh.2026.101804.
• Sompa SI, Larsson P, Ji J, Sjögren B, Upadhyay S, Ganguly K, Josefson M, Bergström A, Olin A-C, Palmberg L. Investigating the exhaled lipid biomarkers among e-cigarette users compared to non-smokers. Lipids in Health and Disease. 2026;25:102. DOI: 10.1186/s12944-026-02911-8.
• Lischnig A, Karimi N, Larsson P, Ekström K, Crescitelli R, Olin A-C, Lässer C. Proteomic and Lipidomic Profiling of Immune Cell-Derived Subpopulations of Extracellular Vesicles. Proteomics. 2026:e70096. DOI: 10.1002/pmic.70096.
• Bonzanini V, Savolainen O, Morales Palomo S, Haddad Momeni M, Olsson L, Geijer C. Optimization of a fatty acid methyl ester protocol for quantification of odd- and even-chain fatty acids in yeast. AMB Express.2026;16:23. DOI: 10.1186/s13568-026-02022-8.
• Otto M, Muñiz-Calvo S, Gossing M, David F, Siewers V. Engineering Saccharomyces cerevisiae to improve heterologous abscisic acid production. Microbial Cell Factories. 2026;25:24. DOI: 10.1186/s12934-025-02913-8.
• Hassenberg C, Soukup ST, Armeni M, Bub A, Cannas JV, Fuentes D, Savolainen O, Seifert S, Landberg R, Kulling SE, Mack CI. Method development and validation for quantitative determination of urinary biomarkers of food intake for multiple foods. Journal of Chromatography B. 2026;1268:124793. DOI: 10.1016/j.jchromb.2025.124793.
2025
• Leite M, Larsson P, Kokelj S, Nordby K-C, Alfonso JH, Koca H, Ulvestad B, Ellingsen DG, Olin A-C. Phospholipid composition in small airway lining fluid among tunnel construction workers exposed to respirable crystalline silica. Lipids in Health and Disease. 2025;24:382. DOI: 10.1186/s12944-025-02790-5.
• Monfort-Pires M, U-Din M, de Mello V, et al. Cold-induced serum short-chain fatty acids act as markers of brown adipose tissue metabolism in humans. Journal of Clinical Endocrinology & Metabolism. 2025.
• Koistinen V, Meuronen T, Keski-Rahkonen P, et al. Harmonizing human plasma metabolite annotation with Plasma Benchmark. Nature Metabolism. 2025;7:1955–1957.
• Söderberg Veibäck G, Lindahl J, Suneson K, et al. Add-on probiotics for inflammatory depression – A double-blind randomized placebo-controlled trial. Brain, Behavior, and Immunity. 2025;129:348–358.
• Armeni M, Cardilin T, Fristedt R, et al. Avenanthramides and avenacosides as biomarkers of oat intake: a pharmacokinetic study of solid and liquid oat consumption under single and repeated dose conditions. Nutrition Journal. 2025;24:136.
• Unión Caballero A, Meroño T, Åberg S, et al. Metabolite Biomarkers Linking a High-Fiber Rye Intervention with Cardiometabolic Risk Factors: The RyeWeight Study. Journal of Agricultural and Food Chemistry.2025;73:21869–21879.
• Jurado-Sumariva L, González-Domínguez Á, Savolainen O, et al. Insulin resistance as a potential driving force of parental obesity-induced adverse metabolic programming mechanisms in children with obesity. BMC Medicine. 2025;23:458.
• Orrje E, Fristedt R, Rosqvist F, Landberg R, Iggman D. Cafestol and kahweol concentrations in workplace machine coffee compared with conventional brewing methods. Nutrition, Metabolism and Cardiovascular Diseases. 2025;35:103933.
• Lok J, Chen C, Iannone V, et al. Advanced Microbiome Therapeutics Accelerate MASLD Recovery by Restoring Intestinal Microbiota Equilibrium and the Gut-Liver Axis in a Mouse Model. Journal of Agricultural and Food Chemistry. 2025;73:15199–15214.
• Costabile G, Vitale M, Testa R, et al. Daily profiles of plasma short-chain fatty acids after the intake of three different cereal fibers: a randomized controlled study. European Journal of Nutrition. 2025;64:217.
• Bjurström EY, Lasin P, Brunnsåker D, Tiukova IA, King RD. An Investigation of TDA1 Deficiency in Saccharomyces cerevisiae During Diauxic Growth. Yeast. 2025;42:142–156.
• Li X, Wang Y, Chen X, et al. Modular deregulation of central carbon metabolism for efficient xylose utilization in Saccharomyces cerevisiae. Nature Communications. 2025;16:4551.
• Pesu H, Mbabazi J, Mutumba R, et al. Effects of lipid-based nutrient supplements on gut markers in stunted children: Secondary analysis of a randomised trial. Journal of Pediatric Gastroenterology and Nutrition.2025;80:889–898.
• Goedecke JH, Danquah I, Abidha CA, et al. Omics Approach for Personalised Prevention of Type 2 Diabetes Mellitus for African and European Populations (OPTIMA): a protocol paper. BMJ Open. 2025;15:e099108.
• af Segerstad EMH, Ericson-Hallström E, Bokström A, et al. Plasma Alkylresorcinols Is an Objective Biomarker for Gluten Intake in Young Children. Journal of Nutrition. 2025;155:985–993.
• Bonzanini V, Haddad Momeni M, Olofsson K, Olsson L, Geijer C. Impact of glucose and propionic acid on even and odd chain fatty acid profiles of oleaginous yeasts. BMC Microbiology. 2025;25:79.
2024
• da Silva TR, Marchesan LB, Rampelotto PH, et al. Gut microbiota and gut-derived metabolites are altered and associated with dietary intake in women with polycystic ovary syndrome. Journal of Ovarian Research.2024;17:232.
• Jiao X, Fu X, Li Q, et al. De novo production of protoberberine and benzophenanthridine alkaloids through metabolic engineering of yeast. Nature Communications. 2024;15:8759.
• Matic ES, Bernard M, Jernstedt AJ, Grommet AB. Orthogonal Phase Transfer of Oppositely Charged FeII4L6 Cages. Chemistry – A European Journal. 2024:e202403411.
• Magnusson MK, Bas Forsberg A, Verveda A, et al. Exposure of Colon-Derived Epithelial Monolayers to Fecal Luminal Factors from Patients with Colon Cancer and Ulcerative Colitis Results in Distinct Gene Expression Patterns. International Journal of Molecular Sciences. 2024;25.
• González-Domínguez Á, Savolainen O, Domínguez-Riscart J, et al. Probing erythrocytes as sensitive and reliable sensors of metabolic disturbances in the crosstalk between childhood obesity and insulin resistance: findings from an observational study, in vivo challenge tests, and ex vivo incubation assays. Cardiovascular Diabetology. 2024;23:336.
• González-Domínguez Á, Domínguez-Riscart J, Savolainen O, et al. Identifying metabotypes of insulin resistance severity in children with metabolic syndrome. Cardiovascular Diabetology. 2024;23:315.
• Fu J, Zaghen S, Lu H, et al. Reprogramming Yarrowia lipolytica metabolism for efficient synthesis of itaconic acid from flask to semipilot scale. Science Advances. 2024;10:eadn0414.
• Alam MZ, Fristedt R, Landberg R, Kamal-Eldin A. Soluble and hydrolyzable phenolic compounds in date fruits (Phoenix dactylifera L.) by UPLC-QTOF-MS/MS and UPLC-DAD. Journal of Food Composition and Analysis. 2024;132:106354.
• Fristedt R, Ruppert V, Trower T, Cooney J, Landberg R. Quantitation of circulating short-chain fatty acids in small volume blood samples from animals and humans. Talanta. 2024;272:125743.
• Noerman S, Johansson A, Shi L, et al. Fasting plasma metabolites reflecting meat consumption and their associations with incident type 2 diabetes in two Swedish cohorts. American Journal of Clinical Nutrition.2024;119:1280–1292.
• Stråvik M, Hartvigsson O, Noerman S, et al. Biomarker Candidates of Habitual Food Intake in a Swedish Cohort of Pregnant and Lactating Women and Their Infants. Metabolites. 2024;14.
• Yan Y, Schillemans T, Skantze V, Brunius C. Adjusting for covariates and assessing modeling fitness in machine learning using MUVR2. Bioinformatics Advances. 2024;4:vbae051.
• Reder GK, Bjurström EY, Brunnsåker D, et al. AutonoMS: Automated Ion Mobility Metabolomic Fingerprinting. Journal of the American Society for Mass Spectrometry. 2024;35:542–550.
• Iribarren C, Savolainen O, Sapnara M, et al. Temporal stability of fecal metabolomic profiles in irritable bowel syndrome. Neurogastroenterology & Motility. 2024;36:e14741.
• Hartvigsson O, Barman M, Rabe H, et al. Associations of the placental metabolome with immune maturation up to one year of age in the Swedish NICE-cohort. Metabolomics. 2024;20:28.
• Nordin E, Landberg R, Hellström PM, Brunius C. Exploration of differential responses to FODMAPs and gluten in people with irritable bowel syndrome – a double-blind randomized cross-over challenge study.Metabolomics. 2024;20:21.
• Pesu H, Mbabazi J, Mutumba R, et al. Correlates of Plasma Citrulline, a Potential Marker of Enterocyte Mass, among Children with Stunting: A Cross-Sectional Study in Uganda. Journal of Nutrition. 2024;154:765–776.
• Bodén S, Zheng R, Ribbenstedt A, et al. Dietary patterns, untargeted metabolite profiles and their association with colorectal cancer risk. Scientific Reports. 2024;14:2244.
• González-Domínguez Á, Estanyol-Torres N, Brunius C, Landberg R, González-Domínguez R. QComics: Recommendations and Guidelines for Robust, Easily Implementable and Reportable Quality Control of Metabolomics Data. Analytical Chemistry. 2024;96:1064–1072.
• Schillemans T, Yan Y, Ribbenstedt A, et al. OMICs Signatures Linking Persistent Organic Pollutants to Cardiovascular Disease in the Swedish Mammography Cohort. Environmental Science & Technology.2024;58:1036–1047.
• Madsen MTB, Landberg R, Nielsen DS, et al. Effects of Wholegrain Compared to Refined Grain Intake on Cardiometabolic Risk Markers, Gut Microbiota, and Gastrointestinal Symptoms in Children: A Randomized Crossover Trial. American Journal of Clinical Nutrition. 2024;119:18–28.
Have analyses performed at CMSI contributed to a publication?
Please contact us so that the publication can be included in our records and the contribution of the infrastructure can be acknowledged.